ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2025

Combined treatment of inetetamab plus pyrotinib and vinorelbine in managing advanced HER2-positive breast cancer patients (ILLUMINE): a multicenter, retrospective, real-world study.

Nan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.